Amanda Luckock
Family · Twin Falls, IDNPI 1366044935
Payments from drug & device makers
Across 93 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$809
- Otsuka America Pharmaceutical, Inc.$124
- Novo Nordisk$86
- AstraZeneca$68
- Pfizer$68
- Lundbeck LLC$65
- plus $505 from 16 others
What the payments were for
- Food & beverage$1,724100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$112
How this compares
$1,724 in reported general payments places this provider in the 80th percentile of 809 family providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 21 | $22,420 |
| FarxigaDapagliflozin Propanediol | 21 | $18,767 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $6,773 |
| EliquisApixaban | 11 | $6,168 |
| Spiriva RespimatTiotropium Bromide | 11 | $5,762 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $1,895 |
| ValacyclovirValacyclovir Hcl | 11 | $744 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $641 |
| Potassium Chloride | 21 | $541 |
| Lisinopril | 84 | $512 |
| Atorvastatin Calcium | 88 | $455 |
| Nebivolol Hcl | 13 | $408 |
| Duloxetine Hcl | 19 | $376 |
| Omeprazole | 37 | $352 |
| Levothyroxine Sodium | 43 | $350 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $39 | $22,42021 claims |
| AstraZenecaFarxiga | $68 | $18,76721 claims |
| PfizerEliquis | $68 | $6,16811 claims |
| Boehringer IngelheimSpiriva Respimat | $12 | $5,76211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 809 family providers in Idaho.
Other family in Twin Falls
- Clark WyattTwin Falls$6K
- Bobbi BullockNampa$609K
- Michael ParkerMeridian$69K
- Jessica BraksiekBoise$41K
- Travis BlaserBoise$33K
- Alysha SchlackNampa$23K
- Jennifer WatsonCoeur D Alene$21K
- Amber MasseIdaho Falls$17K
- Brian KittelsonMeridian$16K
- Devon MoserBoise$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.